FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 335:1275-1280 October 24, 1996 Number 17 Next

	Full Text PDF Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Lymphangioleiomyomatosis is a rare disease of unknown origin that usually leads to progressive deterioration of lung function and eventual death from respiratory failure. It occurs in women of reproductive age and people with tuberous sclerosis. Lung transplantation is a recent therapeutic approach.

Methods We conducted a retrospective study by questionnaire of 34 patients, treated at 16 transplantation centers, who underwent lung transplantation for end-stage lymphangioleiomyomatosis between 1983 and 1995.

Results Of the 34 patients, 27 received single-lung transplants; 6, bilateral transplants; and 1, a heart–lung transplant. As of August 31, 1995, the actuarial survival calculated by the Kaplan–Meier method was 69 percent after one year and 58 percent after two years. Eighteen patients were alive a mean (±SD) of 33±20 months (range, 3 to 74) after transplantation. Forced expiratory volume in one second increased from 24±12 percent of the predicted value before transplantation to 48±16 percent six months after transplantation. Five early deaths (within one month) were due to hemorrhage (in one patient), acute lung injury (in three), and dehiscence of the bronchial anastomosis (in one). Eleven late deaths (after one month) were due to infections (in eight patients), bronchiolitis obliterans (in two), and metastatic nephroblastoma (in one). Disease-associated problems were extensive pleural adhesions in 18 patients, leading to moderate-to-severe intraoperative hemorrhage in 4; pneumothorax in the native lung after single-lung transplantation in 6 patients; postoperative chylothorax in 3; and recurrent lymphangioleiomyomatosis in the allograft in 1 patient, who died of disseminated aspergillosis.

Conclusions Although disease-related complications are frequent, lung transplantation can be a valuable therapy for patients with end-stage lymphangioleiomyomatosis.

Source Information

From the Department of Internal Medicine (A.B., R.S., E.W.R.) and the Department of Surgery (W.W.), University Hospital of Zurich, Zurich, Switzerland; and the St. Louis International Lung Transplant Registry, St. Louis, and other participating institutions.

Address reprint requests to Dr. Boehler c/o Dr. Speich, Department of Internal Medicine, University Hospital, 8091 Zurich, Switzerland.

Full Text of this Article

This article has been cited by other articles:

• Sahn, S. A. (2009). Pleural Disease. ACCP Pulmonary Med Brd Rev 25: 513-546 [Full Text]  
• Ohara, T., Oto, T., Miyoshi, K., Tao, H., Yamane, M., Toyooka, S., Okazaki, M., Date, H., Sano, Y. (2008). Sirolimus Ameliorated Post Lung Transplant Chylothorax in Lymphangioleiomyomatosis. Ann. Thorac. Surg. 86: e7-e8 [Abstract] [Full Text]  
• Attili, A. K., Kazerooni, E. A. (2007). Case 116: Lymphangioleiomyomatosis. Radiology 244: 303-308 [Full Text]  
• Johnson, S. R. (2006). Lymphangioleiomyomatosis.. Eur Respir J 27: 1056-1065 [Abstract] [Full Text]  
• Young, L. R., Almoosa, K. F., Pollock-BarZiv, S., Coutinho, M., McCormack, F. X., Sahn, S. A. (2006). Patient Perspectives on Management of Pneumothorax in Lymphangioleiomyomatosis. Chest 129: 1267-1273 [Abstract] [Full Text]  
• Almoosa, K. F., Ryu, J. H., Mendez, J., Huggins, J. T., Young, L. R., Sullivan, E. J., Maurer, J., McCormack, F. X., Sahn, S. A. (2006). Management of Pneumothorax in Lymphangioleiomyomatosis: Effects on Recurrence and Lung Transplantation Complications. Chest 129: 1274-1281 [Abstract] [Full Text]  
• Voltolini, L., Luzzi, L., Paladini, P., Biagioli, B., Rottoli, P., Gotti, G. (2005). Urgent Contralateral Pneumonectomy After Single Lung Transplantation for Lymphangioleiomyomatosis. Ann. Thorac. Surg. 80: 2349-2351 [Abstract] [Full Text]  
• Cohen, M M, Pollock-BarZiv, S, Johnson, S R (2005). Emerging clinical picture of lymphangioleiomyomatosis. Thorax 60: 875-879 [Abstract] [Full Text]  
• Date, H., Aoe, M., Nagahiro, I., Shimizu, N. (2004). Living-donor lobar lung transplantation for lymphangioleiomyomatosis. ICVTS 3: 188-190 [Abstract] [Full Text]  
• Dauriat, G., Brugiere, O., Mal, H., Camuset, J., Castier, Y., Leseche, G., Fournier, M. (2003). Refractory chylothorax after lung transplantation for lymphangioleiomyomatosis successfully cured with instillation of povidone. J. Thorac. Cardiovasc. Surg. 126: 875-877 [Full Text]  
• Karbowniczek, M., Astrinidis, A., Balsara, B. R., Testa, J. R., Lium, J. H., Colby, T. V., McCormack, F. X., Henske, E. P. (2003). Recurrent Lymphangiomyomatosis after Transplantation: Genetic Analyses Reveal a Metastatic Mechanism. Am. J. Respir. Crit. Care Med. 167: 976-982 [Abstract] [Full Text]  
• Ryu, J. H., Doerr, C. H., Fisher, S. D., Olson, E. J., Sahn, S. A. (2003). Chylothorax in Lymphangioleiomyomatosis. Chest 123: 623-627 [Abstract] [Full Text]  
• Halabi, S., Convery, R., Curtis, J. M. (2002). Progressive Dyspnea in a 49-Year-Old Woman With Long-standing Epilepsy*. Chest 122: 352-355 [Full Text]  
• Moss, J., DeCastro, R., Patronas, N. J., Taveira-DaSilva, A. (2001). Meningiomas in Lymphangioleiomyomatosis. JAMA 286: 1879-1881 [Abstract] [Full Text]  
• YU, J., ASTRINIDIS, A., HENSKE, E. P. (2001). Chromosome 16 Loss of Heterozygosity in Tuberous Sclerosis and Sporadic Lymphangiomyomatosis. Am. J. Respir. Crit. Care Med. 164: 1537-1540 [Abstract] [Full Text]  
• STRIZHEVA, G. D., CARSILLO, T., KRUGER, W. D., SULLIVAN, E. J., RYU, J. H., HENSKE, E. P. (2001). The Spectrum of Mutations in TSC1 and TSC2 in Women with Tuberous Sclerosis and Lymphangiomyomatosis. Am. J. Respir. Crit. Care Med. 163: 253-258 [Abstract] [Full Text]  
• Paquette, B., Fortier, P.-K., Héroux, J., Thibodeau, P. A, Wagner, R., Liu, J., Cantin, A. (2000). Oestrogen metabolism in lymphangioleiomyomatosis: catechol-O-methyltransferase pathway is not involved. Thorax 55: 574-578 [Abstract] [Full Text]  
• Carsillo, T., Astrinidis, A., Henske, E. P. (2000). Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. Proc. Natl. Acad. Sci. USA 97: 6085-6090 [Abstract] [Full Text]  
• Soriano, C. M., Gaine, S. P., Conte, J. V., Fairman, R. P., White, C., Rubin, L. J. (1999). Anastomotic Pulmonary Hypertension After Lung Transplantation for Primary Pulmonary Hypertension: Report of Surgical Correction. Chest 116: 564-566 [Abstract] [Full Text]  
• Venuta, F., Boehler, A., Rendina, E. A., De Giacomo, T., Speich, R., Schmid, R., Funo Coloni, G., Weder, W. (1999). Complications in the native lung after single lung transplantation. Eur. J. Cardiothorac. Surg. 16: 54-58 [Abstract] [Full Text]  
• Oh, Y.-M., Mo, E. K., Jang, S. H., Yoo, C. G., Kim, Y. W., Seo, J.-W., Han, S. K., Im, J.-G., Shim, Y.-S. (1999). Pulmonary lymphangioleiomyomatosis in Korea. Thorax 54: 618-621 [Abstract] [Full Text]  
• Baron, , Barkovich, A. (1999). MR Imaging of Tuberous Sclerosis in Neonates and Young. Am. J. Neuroradiol. 20: 907-916 [Abstract] [Full Text]  
• Chu, S. C., Horiba, K., Usuki, J., Avila, N. A., Chen, C. C., Travis, W. D., Ferrans, V. J., Moss, J. (1999). Comprehensive Evaluation of 35 Patients With Lymphangioleiomyomatosis. Chest 115: 1041-1052 [Abstract] [Full Text]  
• Johnson, S. (1999). Rare diseases bullet  1: Lymphangioleiomyomatosis: clinical features, management and basic mechanisms. Thorax 54: 254-264 [Full Text]  
• Collins, J., Müller, N. L., Kazerooni, E. A., McAdams, H. P., Leung, A. N., Love, R. B. (1999). Lung Transplantation for Lymphangioleiomyomatosis: Role of Imaging in the Assessment of Complications Related to the Underlying Disease. Radiology 210: 325-332 [Abstract] [Full Text]